Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial
Lara A. Ray, ReJoyce Green, Craig K. Enders, et al.
American Journal of Psychiatry (2021) Vol. 178, Iss. 9, pp. 818-828
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Tobacco and nicotine use
Bernard Le Foll, Megan E. Piper, Christie D. Fowler, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 177
Medications for treating alcohol use disorder: A narrative review
Henry R. Kranzler, Emily E. Hartwell
Alcohol Clinical and Experimental Research (2023) Vol. 47, Iss. 7, pp. 1224-1237
Closed Access | Times Cited: 17
Enhancing translation: A need to leverage complex preclinical models of addictive drugs to accelerate substance use treatment options
Christa Corley, Ashley Craig, Safiyah Sadek, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 243, pp. 173836-173836
Open Access | Times Cited: 4
A global overview of shared genetic architecture between smoking behaviors and major depressive disorder in European and East Asian ancestry
Chao Wang, Qiuyi Pu, Xiaoxiao Mo, et al.
Journal of Affective Disorders (2025) Vol. 375, pp. 10-21
Closed Access
Effects of alcohol and cannabis co-use on salience network resting state functional connectivity in individuals who drink alcohol heavily
Kaitlin R. McManus, Malia A. Belnap, Dylan Kirsch, et al.
Drug and Alcohol Dependence (2025), pp. 112577-112577
Closed Access
Empowering Change: From Evidence to Action in Addiction Care and Research—Overview and Proceedings of the AMERSA 2024 Conference
Elizabeth Salisbury‐Afshar, Megan Buresh, Bradley M. Buchheit, et al.
Substance Use & Addiction Journal (2025)
Closed Access
Effect of Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Among Smokers Who Drink Heavily
Andrea C. King, Ashley Vena, Harriet de Wit, et al.
JAMA Network Open (2022) Vol. 5, Iss. 3, pp. e220951-e220951
Open Access | Times Cited: 20
Endogenous opiates and behavior: 2021
Richard J. Bodnar
Peptides (2023) Vol. 164, pp. 171004-171004
Closed Access | Times Cited: 9
Trends in cigarette use and health insurance coverage among US adults with mental health and substance use disorders
Timothy B. Creedon, Geoffrey Ferris Wayne, Ana M. Progovac, et al.
Addiction (2022) Vol. 118, Iss. 2, pp. 353-364
Open Access | Times Cited: 7
Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers
Erica N. Grodin, Elizabeth M. Burnette, ReJoyce Green, et al.
Drug and Alcohol Dependence (2021) Vol. 225, pp. 108825-108825
Open Access | Times Cited: 7
Cigarette Smoking and Heavy Alcohol Drinking: The Challenges and Opportunities for Combination Treatments
Andrea C. King, Lisa M. Fucito
American Journal of Psychiatry (2021) Vol. 178, Iss. 9, pp. 783-785
Closed Access | Times Cited: 7
Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels
Steven J. Nieto, Craig K. Enders, Katie Witkiewitz, et al.
Alcoholism Clinical and Experimental Research (2022) Vol. 46, Iss. 12, pp. 2258-2266
Closed Access | Times Cited: 4
The Effects of Menstrual Cycle Hormones on Responses to Varenicline and Naltrexone Among Female Heavy Drinking Smokers
ReJoyce Green, Daniel Roche, Lara A. Ray
Alcohol and Alcoholism (2022) Vol. 57, Iss. 5, pp. 609-614
Open Access | Times Cited: 3
TOBACCO USE DISORDER AND DUAL DISORDERS Joint statement by the Spanish Psychiatry Society and the Spanish Dual Disorders Society.
Szerman Néstor, P eacute rez Cort eacute s Juan Carlos, Pinet Cristina, et al.
PubMed (2022) Vol. 50, Iss. Supplement, pp. 77-138
Closed Access | Times Cited: 3
Cannabis and alcohol co-use: The effects of intensity of cannabis use among heavy drinkers
Alexandra Venegas, Han Du, Ziva D. Cooper, et al.
Addictive Behaviors (2022) Vol. 135, pp. 107443-107443
Closed Access | Times Cited: 3
Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Outcomes in Heavy Drinkers at 26-Week Follow-up
L Robinson, Nathan Didier, Riya Thomas, et al.
Journal of Clinical Psychopharmacology (2024)
Closed Access
Treatment of Alcohol Use Disorder
Barbara Mason, Eva C. Ritvo, Antonello Bonci
American Psychiatric Association Publishing eBooks (2024)
Closed Access
Synergistic‐like decreases in alcohol intake following combined pharmacotherapy with GLP‐1 and amylin in male rats
Cajsa Aranäs, Antonia Caffrey, Christian E. Edvardsson, et al.
British Journal of Pharmacology (2024)
Closed Access
The combination of a glucagon-like peptide-1 and amylin receptor agonists reduces alcohol consumption in both male and female rats
Cajsa Aranäs, Christian E. Edvardsson, Lindsay Zentveld, et al.
Acta Neuropsychiatrica (2024), pp. 1-15
Open Access
Chapter 5. Alcohol and Co-occurring Substance Use

American Psychiatric Association Publishing eBooks (2023), pp. 73-108
Closed Access | Times Cited: 1
2021 Articles of Import and Impact
The Editors
American Journal of Psychiatry (2022) Vol. 179, Iss. 1, pp. 17-20
Closed Access | Times Cited: 1
Identifying Treatment Responders to Varenicline for Alcohol Use Disorder Using Two Machine-Learning Approaches
Erica N. Grodin, Amanda Kay Montoya, Alondra Cruz, et al.
Clinical Psychological Science (2023) Vol. 12, Iss. 1, pp. 133-146
Open Access
Approved, Promising, and Experimental Medications for Treatment of Alcohol Use Disorder
András H. Lékó, Mehdi Farokhnia, Lorenzo Leggio
Springer eBooks (2023), pp. 261-288
Closed Access
Nikotin- und Alkoholentwöhnung: Pharmakotherapie mit Vareniclin und Naltrexon?

Suchttherapie (2022) Vol. 23, Iss. 01, pp. 5-6
Closed Access
Nikotin- und Alkoholentwöhnung: Pharmakotherapie mit Vareniclin und Naltrexon?

Fortschritte der Neurologie · Psychiatrie (2022) Vol. 90, Iss. 03, pp. 85-86
Closed Access
Page 1 - Next Page

Scroll to top